Skip to main content
. 2023 Mar 3;13:1136835. doi: 10.3389/fonc.2023.1136835

Figure 7.

Figure 7

(A) The Venn diagram demonstrated the key genes involves in differentially expressed genes and CAFs-related genes; (B) The survival analysis of SLPI; (C) The survival analysis of CENPF; (D) The survival analysis of TOP2A; (E) The survival analysis of OR51E2; (F) The expression of SLPI between normal cohort and prostate cancer cohort; (G) The expression of CENPF between normal cohort and prostate cancer cohort; (H) The expression of TOP2A between normal cohort and prostate cancer cohort; (I) The expression of OR51E2 between normal cohort and prostate cancer cohort; (J) The time-dependent ROC curve of SLPI; (K) The time-dependent ROC curve of CENPF; (L) The time-dependent ROC curve of TOP2A; (M) The time-dependent ROC curve of OR51E2; (N, O) The expression of CENPF protein in normal prostate; (P, Q) The expression of CENPF protein in prostate cancer tissues; (R) The GSVA analysis of CENPF in prostate cancer cohort; (S) The expression level of immune checkpoint-related genes between low and high-expression level of CENPF group; (T) The TIDE score between low- and high- expression level of CENPF group. **: p<0.01; ***: p<0.001, ns: p>0.05.